Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
6.85
-0.03 (-0.44%)
Dec 20, 2024, 4:00 PM EST - Market closed

Immatics Revenue

Immatics had revenue of 50.56M EUR in the quarter ending September 30, 2024, with 753.17% growth. This brings the company's revenue in the last twelve months to 115.50M, up 52.53% year-over-year. In the year 2023, Immatics had annual revenue of 54.00M, down -68.76%.

Revenue (ttm)
115.50M EUR
Revenue Growth
+52.53%
P/S Ratio
5.18
Revenue / Employee
215,895 EUR
Employees
535
Market Cap
817.59M USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202354.00M-118.83M-68.76%
Dec 31, 2022172.83M138.07M397.17%
Dec 31, 202134.76M3.51M11.23%
Dec 31, 202031.25M12.80M69.40%
Dec 31, 201918.45M14.68M389.36%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
agilon health 5.59B
Healthcare Services Group 1.70B
Castle Biosciences 311.88M
Paragon 28 245.00M
Cytek Biosciences 201.21M
Avid Bioservices 150.45M
Prothena Corporation 133.35M
AbCellera Biologics 32.96M
Revenue Rankings